The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia

The international standard protocol for acute lymphoblastic leukaemia (ALL), the most common haemato-oncological pathology at paediatric age, uses anthracyclines as antitumor agents, potentially associated with early or late onset cardiac damage. Currently, echocardiography is the gold standard in t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Radu Letiția Elena, Beldiman Andra, Ghiorghiu Ioana, Oprescu Alina, Arion Constantin, Coliță Anca
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Sciendo 2017-04-01
coleção:	Romanian Journal of Laboratory Medicine
Assuntos:	acute lymphoblastic leukaemia paediatric patients cardiotoxicity;biomarkers
Acesso em linha:	https://doi.org/10.1515/rrlm-2017-0014
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!